NCT05244564 Computer Monitor vs Augmented Reality 3MDR for PTSD PTSD: A Randomized Controlled Trial
| NCT ID | NCT05244564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uniformed Services University of the Health Sciences |
| Condition | Stress Disorders, Post-Traumatic |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-04-30 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-04-30 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective randomized controlled trial comparing two ways of delivering Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) therapy for posttraumatic stress disorder (PTSD). The study seeks 60 volunteers who have PTSD and are eligible for care in the Department of Defense healthcare system. There will be 10-14 therapy sessions that are 60-90 minutes long, about once a week, and symptoms will be assessed before and after the therapy as well as 3 and 6 months after completing therapy. 3MDR asks you to choose pictures and music that are integrated into a virtual reality environment. You will be walking on a treadmill throughout each therapy session, while the therapist stands next to the treadmill and asks you questions about the pictures you chose.
Eligibility Criteria
Inclusion Criteria: * Service member, veteran, retiree, or DEERS-eligible dependent, male or female, at least 18 years or older * Diagnosis of PTSD, as confirmed by the CAPS-5 * Able to ambulate with contact guard assistance or less, and walk unassisted on a treadmill, at a normal pace, for up to 90 minutes continuously Exclusion Criteria: * History of epilepsy or a seizure disorder, other than febrile seizures that occurred during childhood and have not recurred since * History of a psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation * Use of benzodiazepines on a regular basis within the previous 30 days
Contact & Investigator
Michael Roy, MD, MPH
PRINCIPAL INVESTIGATOR
Unformed Services University
Frequently Asked Questions
Who can join the NCT05244564 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stress Disorders, Post-Traumatic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05244564 currently recruiting?
Yes, NCT05244564 is actively recruiting participants. Contact the research team at care4ptsd@gmail.com for enrollment information.
Where is the NCT05244564 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT05244564 clinical trial?
NCT05244564 is sponsored by Uniformed Services University of the Health Sciences. The principal investigator is Michael Roy, MD, MPH at Unformed Services University. The trial plans to enroll 60 participants.